The problem
Rheumatoid arthritis, Long COVID, and Lyme disease share the same underlying patterns: an immune response that continues after it should have resolved. Standard treatment relieves symptoms and controls inflammation, and for many patients that relief is essential.
Beneath the flares and the fatigue sits the dysregulation itself — the reason the inflammation keeps returning.
Regenerative protocols aim to support immune balance alongside tissue repair.
The approach
Every Neorgana protocol is customized and multifactorial — built around the patient’s unique case by a multidisciplinary team, with expert guidance at every step.
It begins with thorough assessment and functional review. Supportive therapies prepare the body and create the right environment; regenerative therapies are administered when the patient is ready; and integration care continues afterward — because regeneration is more than any single administration.
For immune and post-infectious conditions, a plan may draw on cellular and signaling therapies from the Dezawa platform together with immune-directed care — combined according to the case.
Natural Killer (NK) Cells can strengthen the immune system by helping eliminate damaged or inflammatory cells — enhancing protection against infections and supporting tissue repair.
The science
Dezawa MuseCells® were discovered and developed by Dr. Mari Dezawa — Professor and Director of the Department of Stem Cell Biology and Histology at Tohoku University School of Medicine, and one of the most respected scientists in regenerative medicine. They reach Neorgana exclusively through MuseCell Innovations®, the global IP owner.
Browse the publicationsWe respect your privacy. Opening the language menu loads Google Translate, which sets its own cookies.
